Yuzi Zhang

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Zhijie Wang, Jianchun Duan, Shangli Cai et al. · JAMA Oncology · 2019 · 491 citations · Full text

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Zhijie Wang, Jing Zhao, Guoqiang Wang et al. · Cancer Research · 2018 · 258 citations

Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Kai Zhang, Xiaohua Hong, Zhengbo Song et al. · Clinical Cancer Research · 2020 · 134 citations

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

Zhijie Wang, Jianchun Duan, Guoqiang Wang et al. · Journal of Thoracic Oncology · 2019 · 91 citations · Full text

Overall Survival, Medicine, Pathology +6

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

Guibin Qiao, Weitao Zhuang, Bo Dong et al. · BMC Medicine · 2021 · 56 citations · Full text